Altered topological properties of brain functional networks in drug-resistant epilepsy patients with vagus nerve stimulators

Seizure ◽  
2021 ◽  
Author(s):  
Jin Zhu ◽  
Cuiping Xu ◽  
Xi Zhang ◽  
Liang Qiao ◽  
Xueyuan Wang ◽  
...  
2019 ◽  
Vol 20 (3) ◽  
pp. 189-198 ◽  
Author(s):  
Laura Pérez-Carbonell ◽  
Howard Faulkner ◽  
Sean Higgins ◽  
Michalis Koutroumanidis ◽  
Guy Leschziner

Vagus nerve stimulation (VNS) is a neuromodulatory therapeutic option for drug-resistant epilepsy. In randomised controlled trials, VNS implantation has resulted in over 50% reduction in seizure frequency in 26%–40% of patients within 1 year. Long-term uncontrolled studies suggest better responses to VNS over time; however, the assessment of other potential predictive factors has led to contradictory results. Although initially designed for managing focal seizures, its use has been extended to other forms of drug-resistant epilepsy. In this review, we discuss the evidence supporting the use of VNS, its impact on seizure frequency and quality of life, and common adverse effects of this therapy. We also include practical guidance for the approach to and the management of patients with VNS in situ.


2020 ◽  
Vol 8 (3) ◽  
pp. 138-148
Author(s):  
Xiaoya Qin

Vagus nerve stimulation (VNS) is a neuromodulation therapy increasingly used for treating drug-resistant epilepsy. However, it remains to be determined which patients are best suited for the treatment, and it is difficult to predict the therapeutic effect before the implantation. Mutations in some genes could lead to epilepsy. Here we report two cases of pediatric patients with drug-resistant epilepsy treated by VNS therapy: Patient 1 with ARX mutation achieved good outcomes; Patient 2 with the CDKL5 mutation did not show improvement. Additionally, the therapeutic impact of VNS on brain networks was investigated, hoping to provide some empirical evidence for a better understanding of the mechanism of VNS treatment.


2020 ◽  
Vol 22 (3) ◽  
pp. 23-30
Author(s):  
S. A. Katyshev ◽  
T. A. Skoromets ◽  
A. G. Naryshkin ◽  
A. V. Vtorov ◽  
M. N. Klochkov ◽  
...  

Currently, the effectiveness of medical and surgical treatment of focal forms does not exceed 75 %. In cases when control over attacks by means of conservative therapy is not possible, and resection indications for surgical intervention are not present, the use of vagus nerve electrical stimulation is recommended.The study objective is to evaluate the effectiveness of vagus nerve electrical stimulation in treatment of drug-resistant epilepsy depending on the type of the disease and patient age.Materials and methods. Retrospective analysis of treatment results of 45 patients (22 children between 2 and 17 years of age (mean age 12.3 years) and 23 adults between 18 and 62 years of age (mean age 29.4 years)) with drug-resistant epilepsy was performed. All patients were implanted with electric stimulator of the left vagus nerve. Control examination was carried out 1 year after surgery, the evaluation method – McHugh scale.Results. In the child group, the results corresponded to class I per the McHugh sale in 30 % of cases, class II – in 26 %; class III – in 26 %, class IV – in 18 %. In the adult group, the results corresponded to class I in 18 % of cases, class II – in 19 %, class III – in 37 %, class IV – in 26 %. In patients with duration of the disease >10 years, results of electrical stimulation were good or excellent in 44 % of cases, for patients with duration between 5 and 10 years – in 40 % of cases, with duration <5 years – in 60 %, but due to small sample size the results are not statistically significant. In patients with simple partial seizures, the treatment was effective in 4 (54 %) of 7 cases, in patients with generalized seizures – in 16 (42.8 %) of 38 cases. The best results were also obtained for interventions in patients between 10 and 15 years of age.Conclusion. Children respond better to vagus nerve electrical stimulation; in the adult age group, it is noted that patients with aura have a better response to therapy with vagus nerve electrical stimulation; smaller epianamnesis is associated with better efficiency; patients with symptomatic epilepsy have a worse response to therapy, than patients with cryptogenic epilepsy; there were no gender differences in the effectiveness of vagus nerve electrical stimulation.


2018 ◽  
Vol 10 ◽  
pp. 78-81 ◽  
Author(s):  
Eduardo Gutiérrez-Maldonado ◽  
Claudia Ivette Ledesma-Ramírez ◽  
Adriana Cristina Pliego-Carrillo ◽  
José Javier Reyes-Lagos

Sign in / Sign up

Export Citation Format

Share Document